Delivery Order SPE2DB22D2206-SPE2DB25FHS91
- Not listed
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRULICITY 3 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a ceiling value of $1,502.79 and a period of performance through July 2, 2025. This order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA to supply a wide range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $1,801.80 and a period of performance through March 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a $1,501.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a diabetes medication, with an ultimate completion date of April 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a $1,351.35 firm-fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a period of performance through July 10, 2025 and was awarded on July 9, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides comprehensive global...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,526.26 contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The $3,277.42 contract has a completion date of June 24, 2025 and is not a set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply TRULICITY 3 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a ceiling value of $4,071.35 and a completion date of July 16, 2025. The contract is a firm fixed price delivery order and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $3,603.60 and a completion date of June 13, 2025. The contract is a firm-fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a $3,778.65 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a diabetes medication. The order has a completion date of July 8, 2025 and is not a set-aside contract. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the company to provide a wide...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $2,402.40 and a performance period ending on June 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHS91Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $1,801.80 and a period of performance through July 2, 2025. The contract is not set aside and was awarded on July 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/1/25 |